[1].GUO Kang-xiao,YIN Kang-kang, WANG Huan, et al. The effect of modeling dysbacterial diarrhea with antibiotics on molecular diversity of intestinal microbiota in mice.[J] Chinese Journal of Microecology,Mar. 2014,Vol. 26 No. 3
[2].FAN Ting-ting. Study on regulation of antibiotics abuse in our country[C]Nanjing University of Chinese Medicine,Master Thesis,2012.
[3].Jonathan P, Jacobs, Maryam Goudarzi, Namita Singh, et al. A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients.[J] Cell Mol Gastroenterol Hepatol 2016;2:750–766;
[4].GAO Yun. Study on the abuse of antibiotics and the use of mistakes[J]. Mod Chin Med,2011,18( 5) : 113.
[5].World Health Organization. Diarrheal disease. In: Fact Sheet Number 330. 2013. http://www.who.int/mediacentre/factsheets/fs330/en/.
[6].Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of noro-virus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):725–30.
[7]. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–61.
[8].Janelle A. Jiminez, Trina C. Uwiera, G. Douglas Inglis, Richard R. E. Uwiera. Animal models to study acute and chronic intestinal inflammation in mammals.[J]Gut Pathog (2015) 7:29.
[9].Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014;20(1):6–21.
[10].Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):3–10.
[11].Janeway CAJ, Travers P, Walport M, Sclomchik MJ. Immunobiology: the immune system in health and disease. 5th ed. New York: Garland Science;2001.
[12].Geiger BM, Gras-Miralles B, Ziogas DC,et al. Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish. PLoS One.2013;8(12):e83194
[13].Fitzpatrick LR, Meirelles K, Small JS, Puleo FJ, Koltun WA, Cooney RN. A new model of chronic hapten-induced colitis in young rats. J Pediatr Gastroenterol Nutr. 2010;50(3):240–50.
[14]. Krimi RB, Kotelevets L, Dubuquoy L,et al. Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm Bowel Dis.2008;14(7):931–41.
[15].Barthel M, Hapfelmeier S, Quintanilla-Martinez L,et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71(5):2839–58.
[16].Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol. 2011;89(5):685–95.
[17].Hedin C, McCarthy N, Louis P, et al. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn’s disease and their unaffected siblings. Gut. 2014; 63(10):1578–86.
[18].Nguyen GC. Bugs and Drugs: Insights into the Pathogenesis of Inflammatory Bowel Disease. American Journal of Gastroenterology. 2011; 106:2143–5.
[19].Sokol H, Lay C, Seksik P, et al. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflammatory Bowel Diseases. 2008; 14(6):858–67.
[20].Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut. 2011; 60:631–7.
[21].Chelsia Gillis, Marlyn Gill, Nancy Marlett, et al.Patients as partners in Enhanced Recovery After Surgery: A qualitative patient-led study.BMJ Open. 2017; 7(6): e017002.Published online 2017 Jun 24.doi:10.1136/bmjopen-2017-017002
[22].W. R. Spanjersberg, J. D. P. van Sambeeck, A. Bremers, C. Rosman, C. J. H. M. van Laarhoven. Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme.Surg Endosc.2015; 29(12): 3443–3453. Published online 2015 Mar 24.doi:10.1007/s00464-015-4148-3
[23]. Leah M. Gramlich, Caroline E. Sheppard, Tracy Wasylak, et al. Implementation of Enhanced Recovery After Surgery: a strategy to transform surgical care across a health system.Implement Sci.2017;12:67. Published online 2017 May 19.doi:10.1186/s13012-017-0597-5
[24].Ester Miralpeix, Alpa M. Nick, Larissa A. Meyer, et al. A Call for New Standard of Care in Perioperative Gynecologic Oncology Practice: Impact of Enhanced Recovery After Surgery (ERAS) Programs.Gynecol Oncol. 2016 May; 141(2):371-378.Published online 2016 Mar 9.doi:10.1016/j.ygyno.2016.02.019
[25]. Morales W, Pimentel M, Hwang L, et al. Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS. Dig Dis Sci.2011;56(9):2575–84. doi:10.1007/s10620-011-1662-6.
[26]. Abnous K, Brooks SP, Kwan J, et al. Diets enriched in oat bran or wheat bran temporally and differentially alter the composition of the fecal community of rats. J Nutr. 2009;139(11):2024–31. doi:10.3945/jn.109.109470
[27]. Kalmokoff M, Zwicker B, O’Hara M, et al. Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate.availability. J Appl Microbiol. 2013;114(5):1516–28. doi:10.1111/jam.12157.
[28].Sha Di, Yitian Wang, Lin Han, Qi Bao, Zezheng Gao, Qing Wang, Yingying Yang, Linhua Zhao, Xiaolin Tong. The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders. Evid Based Complement Alternat Med.2019;2019: 2958920.Published online 2019 Jun 4.doi:10.1155/2019/2958920
[29].Lipid metabolism group. Expert consensus on the prevention and treatment of type 2 diabetes mellitus with dyslipidemia in China (revised version in 2017) Chinese Journal of Endocrinology and Metabolism. 2017;33(11)
[30]. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–9. doi:10.1126/science.1124234.
[31].Hoffmann C, Hill DA, Minkah N, et al. Communitywide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun. 2009;77(10):4668–78. doi:10.1128/IAI.00493-09.
[32].Shen XJ, Rawls JF, Randall T, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010;1(3):138–47.doi:10.4161/gmic.1.3.12360
[33].Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev. 2004;9(2):180–97.
[34].Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;339(6116):166–72. doi:10.1126/ science.1230720
[35].Sherman MA, Kalman D. Initiation and resolution of mucosal inflammation. Immunol Res. 2004;29(1–3):241–52. doi:10.1385/ IR:29:1-3:241.
[36].Arianna K. DeGruttola, B.S., Daren Low, Ph.D., Atsushi Mizoguchi, M.D., Ph.D.2, and Emiko Mizoguchi, M.D., Ph.D.1,2.Current understanding of dysbiosis in disease in human and animal models.Inflamm Bowel Dis. 2016 May; 22(5): 1137–1150. doi:10.1097/MIB.0000000000000750
[37]. Steven Y. C. Tong, Joshua S. Davis, Emily Eichenberger, Thomas L. Holland, Vance G. Fowler, Jr.Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin Microbiol Rev. 2015 Jul;28(3): 603–661.Published online 2015 May 27.doi:10.1128/CMR.00134-14
[38].Divya Balasubramanian, Lamia Harper, Bo Shopsin, Victor J. Torres. Staphylococcus aureus pathogenesis in diverse host environments. Pathog Dis. 2017 Feb;75(1): ftx005. Published online 2017 Jan 19.doi:10.1093/femspd/ftx005
[39]. Diana Oliveira, Anabela Borges, Manuel Simões. Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. Toxins (Basel) 2018 Jun; 10(6): 252.Published online 2018 Jun 19. doi: 10.3390/toxins10060252.
[40]. Kim BJ, Park T, Moon HC, et al. Cytoprotective alginate/polydopamine core/shell microcapsules in microbial encapsulation. Angew Chem Int Ed Engl.2014;53(52):14443–14446.
[41]. Mei L, He F, Zhou RQ, et al. Novel intestinal-targeted Ca-alginate-based carrier for pH-responsive protection and release of lactic acid bacteria.ACS Appl Mater Interfaces.2014;6(8):5962–5970.
[42]. D’Orazio G, Di Gennaro P, Boccarusso M, et al. Microencapsulation of new probiotic formulations for gastrointestinal delivery in vitro study to assess viability and biological properties. Appl Microbiol Biotechnol.2015;99(22):9779–9789.
[43]. Maria C Dzialo, Rahel Park, Jan Steensels, Bart Lievens, Kevin J Verstrepen. Physiology, ecology and industrial applications of aroma formation in yeast.FEMS Microbiol Rev. 2017 Aug; 41(Suppl 1): S95–S128. Published online 2017 Aug 17.doi:10.1093/femsre/fux031
[44]. Olga Ponomarova, Natalia Gabrielli, Daniel C. Sévin, Michael Mülleder, Katharina Zirngibl, Katsiaryna Bulyha, Sergej Andrejev, Eleni Kafkia, Athanasios Typas, Uwe Sauer, Markus Ralser, Kiran Raosaheb Patil. Yeast Creates a Niche for Symbiotic Lactic Acid Bacteria through Nitrogen Overflow. Cell Syst.2017 Oct 25;5(4): 345–357.e6.doi:10.1016/j.cels.2017.09.002
[45]. Masanori Horie, Takamasa Miura, Satomi Hirakata, Akira Hosoyama, Sakiko Sugino, Aya Umeno, Kazutoshi Murotomi, Yasukazu Yoshida, Taisuke Koike. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice. Exp Anim. 2017;66(4): 405–416. Published online 2017 Jul 12. doi: 10.1538/expanim.17-0021
[46]. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., Gordon J.I. 2009. A core gut microbiome in obese and lean twins. Nature 457: 480–484. doi: 10.1038/nature07540
[47]. Paredes CJ, Alsaker KV, Papoutsakis ET. 2005.A comparative genomic view of clostridial sporulation and physiology.Nat Rev Microbiol 3:969–978. doi:10.1038/nrmicro1288.
[48]. Wiep Klaas Smits, Dena Lyras, D. Borden Lacy, Mark H. Wilcox, Ed J. Kuijper. Clostridium difficile infection. Nat Rev Dis Primers. Author manuscript; available in PMC 2017 Jun 1.
[49]. L Clifford McDonald, Dale N Gerding, Stuart Johnson, Johan S Bakken, Karen C Carroll, Susan E Coffin, Erik R Dubberke, Kevin W Garey, Carolyn V Gould, Ciaran Kelly, Vivian Loo, Julia Shaklee Sammons, Thomas J Sandora, Mark H Wilcox. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis.2018 Apr 1;66(7): e1–e48.Published online 2018 Feb 15.doi:10.1093/cid/cix1085
[50]. Márió Gajdács, Gabriella Spengler, Edit Urbán. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology?. Antibiotics(Basel) 2017 Dec;6(4): 25.Published online 2017 Nov 7.doi:10.3390/antibiotics6040025
[51]. Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska, B. Brett Finlay. Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clin Microbiol Rev.2013 Oct;26(4): 822–880.doi:10.1128/CMR.00022-13
[52] Zachary R. Stromberg, James R. Johnson, John M. Fairbrother, Jacquelyn Kilbourne, Angelica Van Goor, Roy Curtiss, 3rd, Melha Mellata. Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health. PLoS One. 2017; 12(7): e0180599. Published online 2017 Jul 3. doi: 10.1371/journal.pone.0180599
[53] Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska, B. Brett Finlay. Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clin Microbiol Rev. 2013 Oct; 26(4): 822–880. doi: 10.1128/CMR.00022-13
[54].Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol.2:123–140
[55].Croxen MA, Finlay BB. 2010.Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol.8:26–38
[56]. Edyta Golińska, Anna Tomusiak, Tomasz Gosiewski, Grażyna Więcek, Agnieszka Machul, Diana Mikołajczyk, Małgorzata Bulanda, Piotr B Heczko, Magdalena Strus. Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease. World J Gastroenterol.2013 Jun 21;19(23): 3562–3572.Published online 2013 Jun 21.doi:10.3748/wjg.v19.i23.3562
[57].Raffael C. Inglin, Leo Meile, Marc J. A. Stevens. Clustering of Pan- and Core-genome of Lactobacillus provides Novel Evolutionary Insights for Differentiation. BMC Genomics. 2018; 19: 284.Published online 2018 Apr 24.doi:10.1186/s12864-018-4601-5
[58]. eurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 2002;8(6):567–73. doi:10.1038/nm0602-567.
[59].Yohei Kanamori, Masaru Murakami§, Makoto Sugiyama, Osamu Hashimoto, Tohru Matsui, Masayuki Funaba‡.Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding proteinδ(C/EBPδ)expression in hepatocytes. J. Biol. Chem. (2017) 292(24) 10275–10287
[60].P.T. Lee, S. Bird, J. Zou, S.A.M. Martin.Phylogeny and expression analysis of C-reactive protein (CRP) and serum amyloid-P (SAP) like genes reveal two distinct groups in fish. Fish Shellfish Immunol. 2017 Jun; 65: 42–51.doi:10.1016/j.fsi.2017.03.037
[61].Manu Sudhakar, Santhi Silambanan, Abhinand S. Chandran, Athira A. Prabhakaran, Ramya Ramakrishnan.C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor.Front Immunol.2018;9: 1167.Published online 2018 May 29. doi: 10.3389/fimmu.2018.01167
[62].Chi-Dung Yang, Hsi-Yuan Huang, Sirjana Shrestha, et al. Large-Scale Functional Analysis of CRP-Mediated Feed-Forward Loops.Int J Mol Sci. 2018 Aug;19(8): 2335. Published online 2018 Aug 9.doi:10.3390/ijms19082335
[63].Ann Kathrin Heroven, Maike Sest, Fabio Pisano,et al.Front Cell Infect Microbiol.2012;2:158. Published online 2012 Dec 17.doi:10.3389/fcimb.2012.00158